Multicentre validation of IMRT pre-treatment verification: Comparison of in-house and external audit

被引:27
|
作者
Jornet, Nuria [1 ]
Carrasco, Pablo [1 ]
Beltran, Merce [2 ]
Francisco Calvo, Juan [3 ]
Escude, Lluis [4 ]
Hernandez, Victor [5 ]
Quera, Jaume [6 ]
Saez, Jordi [2 ]
机构
[1] Hosp Santa Creu & Sant Pau, Serv Radiofis & Radioproteccio, Barcelona, Spain
[2] Hosp Vall dHebro, Serv Fis, Barcelona, Spain
[3] Hosp Quiron, Serv Oncol Radioterap, Barcelona, Spain
[4] Clin Teknon, Serv Oncol Radioterap, Barcelona, Spain
[5] Hosp St Joan, Serv Fis, Reus, Spain
[6] Hosp Esperanza, Serv Oncol Radioterap, Barcelona, Spain
关键词
IMRT; Audit; Quality assurance; MODULATED RADIATION-THERAPY; RADIOCHROMIC FILM DOSIMETRY; QUALITY-ASSURANCE; EBT2; FILM; RADIOTHERAPY; COMPLEXITY; INDEX; QA;
D O I
10.1016/j.radonc.2014.06.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: We performed a multicentre intercomparison of IMRT optimisation and dose planning and IMRT pre-treatment verification methods and results. The aims were to check consistency between dose plans and to validate whether in-house pre-treatment verification results agreed with those of an external audit. Materials and methods: Participating centres used two mock cases (prostate and head and neck) for the intercomparison and audit. Compliance to dosimetric goals and total number of MU per plan were collected. A simple quality index to compare the different plans was proposed. We compared gamma index pass rates using the centre's equipment and methodology to those of an external audit. Results: While for the prostate case, all centres fulfilled the dosimetric goals and plan quality was homogeneous, that was not the case for the head and neck case. The number of MU did not correlate with the plan quality index. Pre-treatment verifications results of the external audit did not agree with those of the in-house measurements for two centres: being within tolerance for in-house measurements and unacceptable for the audit or the other way round. Conclusions: Although all plans fulfilled dosimetric constraints, plan quality is highly dependent on the planner expertise. External audits are an excellent tool to detect errors in IMRT implementation and cannot be replaced by intercomparison using results obtained by centres. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:381 / 388
页数:8
相关论文
共 50 条
  • [11] Comparison of time-benefit ratio between in vivo dosimetry and pre-treatment verification in IMRT breast treatment
    Bermejo, S.
    Ventosa, N.
    Domenech, X.
    Flores, R.
    De Segura, G. Gomez
    Jimenez, J.
    Nolla, X.
    Martin, L. San
    Carrasco, P.
    Latorre, A.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S898 - S899
  • [12] Validation of in-house and external softwares at aerospatiale
    Sourisseau, J.-C.
    Locatelli, J.
    RFM, Revue Francaise de Mecanique, 1988, (03): : 27 - 30
  • [13] Multi-centre audit of VMAT planning and pre-treatment verification
    Jurado-Bruggeman, Diego
    Hernandez, Victor
    Saez, Jordi
    Navarro, David
    Pino, Francisco
    Martinez, Tatiana
    Alayrach, Maria-Elena
    Ailleres, Norbert
    Melero, Alejandro
    Jornet, Nuria
    RADIOTHERAPY AND ONCOLOGY, 2017, 124 (02) : 302 - 310
  • [14] Clinical experience with EPID dosimetry for prostate IMRT pre-treatment dose verification
    McDermott, L. N.
    Wendling, M.
    van Asselen, B.
    Stroom, J.
    Sonke, J. -J.
    van Herk, M.
    Mijnheer, B. J.
    MEDICAL PHYSICS, 2006, 33 (10) : 3921 - 3930
  • [15] Portal Dosimetry for Pre-Treatment Verification of IMRT Plan: A Comparison with 2D Ion Chamber Array
    Sharma, D.
    Mhatre, V.
    Heigrujam, M.
    Talapatra, K.
    Mallik, S.
    MEDICAL PHYSICS, 2010, 37 (06) : 3234 - +
  • [16] Impact of Verification Planning Phantom Geometry to the Pre-Treatment IMRT QAGamma Passing Rate
    Su, M.
    Tena, L.
    Sura, S.
    MEDICAL PHYSICS, 2017, 44 (06) : 2897 - 2897
  • [17] Dosimetric pre-treatment IMRT verification with a new CCD camera based fluoroscopic EPID
    Pasma, KL
    Bolt, RA
    Mestrom, LHM
    Huizenga, H
    Bal, M
    Spies, L
    Visser, AG
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S115 - S115
  • [18] The efficacy of applying heterogeneity correction factors on ArcCHECK for IMRT and VMAT pre-treatment verification
    Lam, W. W.
    Geng, H.
    Kong, C. W.
    Cheung, K. Y.
    Yu, S. K.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S157 - S158
  • [19] First clinical experience with pre-treatment and in vivo IMRT verification using EPID dosimetry
    McDermott, LN
    Wendling, M
    Sonke, J
    Stroom, J
    van Asselen, B
    van Herk, M
    Mijnheer, B
    MEDICAL PHYSICS, 2005, 32 (06) : 2090 - 2090
  • [20] Patient Specific IMRT Pre-Treatment Verification Using A Commercial Portal Dosimetry Software
    Varatharaj, C.
    Moretti, E.
    Manickam, R.
    Padovani, R.
    MEDICAL PHYSICS, 2012, 39 (06) : 3788 - 3788